Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow Reinvestment Rate
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting CN¥123.12 Million (capex CN¥123.12 Million ) from operating cash flow of CN¥345.31 Million. Check cash flow quality index of Jiangsu Hualv Biological Technology Co.L to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. Explore Jiangsu Hualv Biological Technology Co.L debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year capital reinvestment analysis for Jiangsu Hualv Biological Technology Co.Ltd.. For live market cap and broader valuation context, see 300970 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.36x | CN¥123.12 Million | CN¥345.31 Million | CN¥123.12 Million | ▼ -90.8% |
| 2024 | 3.89x | CN¥536.45 Million | CN¥137.80 Million | CN¥268.22 Million | ▲ +100.0% |
| 2023 | 1.95x | CN¥324.39 Million | CN¥166.67 Million | CN¥224.15 Million | ▼ -15.3% |
| 2022 | 2.30x | CN¥413.20 Million | CN¥179.84 Million | CN¥407.91 Million | ▼ -77.5% |
| 2021 | 10.20x | CN¥847.81 Million | CN¥83.08 Million | CN¥204.09 Million | ▲ +487.3% |
| 2020 | 1.74x | CN¥345.91 Million | CN¥199.09 Million | CN¥190.96 Million | ▲ +39.1% |
| 2019 | 1.25x | CN¥267.34 Million | CN¥213.96 Million | CN¥98.54 Million | — |